Listed

ProPhase Labs, Inc.: Form 10-K for the period ended Dec 31, 2016

Filed with the SEC on Feb 24, 2017 and accepted by EDGAR at Feb 24, 2017, 21:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2016-01-01 to 2016-12-31$21.0mus-gaap:SalesRevenueNet
Cost of revenue12 months2016-01-01 to 2016-12-31$10.9mus-gaap:CostOfGoodsAndServicesSold
Gross profit12 months2016-01-01 to 2016-12-31$10.1mus-gaap:GrossProfit
Research and development12 months2016-01-01 to 2016-12-31$575.0kus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2016-01-01 to 2016-12-31−$2.7mus-gaap:OperatingIncomeLoss
Interest expense12 months2016-01-01 to 2016-12-31$213.0kus-gaap:InterestExpense
Net income12 months2016-01-01 to 2016-12-31−$2.9mus-gaap:NetIncomeLoss
Operating cash flow12 months2016-01-01 to 2016-12-31−$472.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2016-01-01 to 2016-12-31$651.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-12-31$441.0kus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$9.6mus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$12.8mus-gaap:Assets
Current liabilitiesAt period end2016-12-31$6.8mus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2016-12-31$6.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-17-001890. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.